Clinical Trial Update: The Effect of High-dose Remifentanil on Established Capsaicin-induced Hyperalgesia in Human Volunteers [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating whether high-dose remifentanil modulates capsaicin-induced hyperalgesia in healthy human volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperalgesia

Drugs mentioned

• Remifentanil (remifentanil)

Snippet

Sponsor: Medical University of Vienna | Conditions: Hyperalgesia | Phase 4 | Status: UNKNOWN